PTC
BIIB icon

Peak Ten Capital’s Biogen BIIB Stock Holding History

Peak Ten Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$1.31M Buy
+4,500
New +$1.49M 2.82% 17

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Peak Ten Capital's BIIB Position: Q3 2015 in Review

Peak Ten Capital opened a new position in Biogen (BIIB) in Q3 2015: 4,500 shares worth $1.31M. The stake represents 2.82% of the portfolio and ranks #17 among its holdings.

923 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

  • Peak Ten Capital held 4,500 shares of Biogen worth $1.31M as of Q3 2015.
  • Biogen was a new Peak Ten Capital position in Q3 2015.
  • Biogen made up 2.82% of Peak Ten Capital's portfolio in Q3 2015, its #17 holding.
  • 923 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on Peak Ten Capital's 13F filing for Q3 2015, filed 16 Nov 2015.